Mar 11 2010
Assessing The Market For Constipation Remedies
According to surveyors from both academia and the pharmaceutical industry, the general population experiences a 10% incidence rate of constipation. Such a high incidence means that there is a large market for medications and supplements targeted toward constipation, and that the number of players in the market that supply these treatment agents is correspondingly large.
Many entrepreneurs interested in entering the market for supplying constipation treatments may be discouraged by what may seem to be a mature, stable and saturated market. The real situation however, is both more hopeful and bleak simultaneously. The reason is that there are few if any constipation remedies that are effective for everyone all the time. The market is split into various treatments of varying efficacy, with little diagnostics to distinguish which patients benefit from which treatments.
Currently, the treatment market can be divided into 4 types. There are supplemental agents, which don’t require FDA approval. There are herbal agents, which usually fall outside FDA jurisdiction but has occasionally experienced periods of regulation. There are general laxative agents that are either over-the-counter or by prescription. There are the new “targeted therapies” that attempt to address molecular and hormonal causes of constipation.
Nutritional supplements include among them distinguished brands like Metamucil, the main ingredients of which are usually some natural product with exceptionally high fiber. For example, psyllium husks from the Plantago shrub are high in fiber and used in supplements. They are often found in powdered form so as to be mixed with water to make a drinkable source of fiber.
By and large, herbal supplements are synonymous with senna, which are rich in sennosides, a class of compounds that stimulates the intestine. The constipation treatment market used to be much more crowded with other herbal supplements like aloe and cascara, but the FDA has since then cracked down on new entrants to the field because of safety concerns. Some manufacturers still produce aloe-based herbal supplements in concordance with the law.
By far the most active segment of the constipation treatment market is the over-the-counter (OTC) and prescription medication category. The medicines are all quite different in their mode of action, individual efficacy and cost. It’s likely that a patient will have to try out a few before finding one that works well. Some examples of these include stimulant laxatives and lubricant laxatives.
Finally, a new generation of medicines known as “molecular” medicines await approval from the FDA. The first of these, amitiza, directly fires a protein receptor in sensor cells of the intestine which cause fluid secretion and spontaneous bowel movement. General laxatives operate through unclear mechanisms usually with empirical bases, whereas amitiza and other agents were designed for a specific mechanism. The result is a more targeted medication, and one that has achieved elusive acceptance by the FDA for treating chronic constipation.
This and related topics on treating constipation are available to everyone. Some of these ideas were generously supplied by a site on prokinetic treatments for constipation .




